Literature DB >> 30129122

Contribution of the commensal microbiota to atherosclerosis and arterial thrombosis.

Klytaimnistra Kiouptsi1, Christoph Reinhardt1,2.   

Abstract

The commensal gut microbiota is an environmental factor that has been implicated in the development of cardiovascular disease. The development of atherosclerotic lesions is largely influenced not only by the microbial-associated molecular patterns of the gut microbiota but also by the meta-organismal trimethylamine N-oxide pathway. Recent studies have described a role for the gut microbiota in platelet activation and arterial thrombosis. This review summarizes the results from gnotobiotic mouse models and clinical data that linked microbiota-induced pattern recognition receptor signalling with atherogenesis. Based on recent insights, we here provide an overview of how the gut microbiota could affect endothelial cell function and platelet activation, to promote arterial thrombosis. LINKED ARTICLES: This article is part of a themed section on When Pharmacology Meets the Microbiome: New Targets for Therapeutics? To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.24/issuetoc.
© 2018 The British Pharmacological Society.

Entities:  

Mesh:

Year:  2018        PMID: 30129122      PMCID: PMC6255953          DOI: 10.1111/bph.14483

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  94 in total

1.  Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis.

Authors:  Zeneng Wang; Adam B Roberts; Jennifer A Buffa; Bruce S Levison; Weifei Zhu; Elin Org; Xiaodong Gu; Ying Huang; Maryam Zamanian-Daryoush; Miranda K Culley; Anthony J DiDonato; Xiaoming Fu; Jennie E Hazen; Daniel Krajcik; Joseph A DiDonato; Aldons J Lusis; Stanley L Hazen
Journal:  Cell       Date:  2015-12-17       Impact factor: 41.582

2.  Microbiota-derived compounds drive steady-state granulopoiesis via MyD88/TICAM signaling.

Authors:  Maria L Balmer; Christian M Schürch; Yasuyuki Saito; Markus B Geuking; Hai Li; Miguelangel Cuenca; Larisa V Kovtonyuk; Kathy D McCoy; Siegfried Hapfelmeier; Adrian F Ochsenbein; Markus G Manz; Emma Slack; Andrew J Macpherson
Journal:  J Immunol       Date:  2014-10-10       Impact factor: 5.422

Review 3.  Mechanisms of erosion of atherosclerotic plaques.

Authors:  Thibaut Quillard; Grégory Franck; Thomas Mawson; Eduardo Folco; Peter Libby
Journal:  Curr Opin Lipidol       Date:  2017-10       Impact factor: 4.776

4.  Impact of macrophage toll-like receptor 4 deficiency on macrophage infiltration into adipose tissue and the artery wall in mice.

Authors:  K R Coenen; M L Gruen; R S Lee-Young; M J Puglisi; D H Wasserman; A H Hasty
Journal:  Diabetologia       Date:  2008-12-04       Impact factor: 10.122

5.  Degradation of various amine compounds by mesophilic clostridia.

Authors:  B Möller; H Hippe; G Gottschalk
Journal:  Arch Microbiol       Date:  1986-06       Impact factor: 2.552

6.  A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes.

Authors:  F P Huang; N Platt; M Wykes; J R Major; T J Powell; C D Jenkins; G G MacPherson
Journal:  J Exp Med       Date:  2000-02-07       Impact factor: 14.307

7.  Constant replenishment from circulating monocytes maintains the macrophage pool in the intestine of adult mice.

Authors:  Calum C Bain; Alberto Bravo-Blas; Charlotte L Scott; Elisa Gomez Perdiguero; Frederic Geissmann; Sandrine Henri; Bernard Malissen; Lisa C Osborne; David Artis; Allan McI Mowat
Journal:  Nat Immunol       Date:  2014-08-24       Impact factor: 25.606

Review 8.  Toll-Like Receptor 4 Signalling and Its Impact on Platelet Function, Thrombosis, and Haemostasis.

Authors:  Thomas M Vallance; Marie-Theres Zeuner; Harry F Williams; Darius Widera; Sakthivel Vaiyapuri
Journal:  Mediators Inflamm       Date:  2017-10-17       Impact factor: 4.711

9.  Uncovering the trimethylamine-producing bacteria of the human gut microbiota.

Authors:  Silke Rath; Benjamin Heidrich; Dietmar H Pieper; Marius Vital
Journal:  Microbiome       Date:  2017-05-15       Impact factor: 14.650

10.  Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity.

Authors:  Thomas B Clarke; Kimberly M Davis; Elena S Lysenko; Alice Y Zhou; Yimin Yu; Jeffrey N Weiser
Journal:  Nat Med       Date:  2010-01-17       Impact factor: 53.440

View more
  12 in total

1.  When pharmacology meets the microbiome: new targets for therapeutics?

Authors:  Niall P Hyland; John F Cryan
Journal:  Br J Pharmacol       Date:  2018-12       Impact factor: 8.739

Review 2.  Contribution of the commensal microbiota to atherosclerosis and arterial thrombosis.

Authors:  Klytaimnistra Kiouptsi; Christoph Reinhardt
Journal:  Br J Pharmacol       Date:  2018-09-25       Impact factor: 8.739

3.  Evaluation of Antioxidant Therapeutic Value of ACE Inhibitor as Adjunct Therapy on Type 2 Diabetes Mellitus Patients with Cardiovascular Disease.

Authors:  Abdulsalam Elfowiris; Ali Banigesh
Journal:  ACS Pharmacol Transl Sci       Date:  2022-05-11

Review 4.  The roles of gut microbiota and circadian rhythm in the cardiovascular protective effects of polyphenols.

Authors:  Andy W C Man; Ning Xia; Andreas Daiber; Huige Li
Journal:  Br J Pharmacol       Date:  2019-10-31       Impact factor: 8.739

Review 5.  The Microbial Metabolite Trimethylamine N-Oxide Links Vascular Dysfunctions and the Autoimmune Disease Rheumatoid Arthritis.

Authors:  Marion M Chan; Xiaofeng Yang; Hong Wang; Fatma Saaoud; Yu Sun; Dunne Fong
Journal:  Nutrients       Date:  2019-08-07       Impact factor: 5.717

Review 6.  Antibiotic Treatment Protocols and Germ-Free Mouse Models in Vascular Research.

Authors:  Franziska Bayer; Stefanie Ascher; Giulia Pontarollo; Christoph Reinhardt
Journal:  Front Immunol       Date:  2019-09-12       Impact factor: 7.561

7.  The Microbiota Promotes Arterial Thrombosis in Low-Density Lipoprotein Receptor-Deficient Mice.

Authors:  Klytaimnistra Kiouptsi; Sven Jäckel; Giulia Pontarollo; Emiel P C van der Vorst; Yvonne Döring; Christoph Reinhardt; Alexandra Grill; Marijke J E Kuijpers; Eivor Wilms; Christian Weber; Felix Sommer; Magdolna Nagy; Carlos Neideck; Yvonne Jansen; Stefanie Ascher; Henning Formes; Cornelia Karwot; Franziska Bayer; Bettina Kollar; Saravanan Subramaniam; Michael Molitor; Philip Wenzel; Philip Rosenstiel; Hristo Todorov; Susanne Gerber; Ulrich Walter; Kerstin Jurk; Johan W M Heemskerk
Journal:  mBio       Date:  2019-10-22       Impact factor: 7.867

Review 8.  The gut microbiome and thromboembolism.

Authors:  Rida Abid Hasan; Andrew Y Koh; Ayesha Zia
Journal:  Thromb Res       Date:  2020-03-06       Impact factor: 3.944

Review 9.  Resveratrol and the Interaction between Gut Microbiota and Arterial Remodelling.

Authors:  Andy W C Man; Huige Li; Ning Xia
Journal:  Nutrients       Date:  2020-01-01       Impact factor: 5.717

10.  The Commensal Microbiota Enhances ADP-Triggered Integrin αIIbβ3 Activation and von Willebrand Factor-Mediated Platelet Deposition to Type I Collagen.

Authors:  Klytaimnistra Kiouptsi; Sven Jäckel; Eivor Wilms; Giulia Pontarollo; Jana Winterstein; Cornelia Karwot; Kathrin Groß; Kerstin Jurk; Christoph Reinhardt
Journal:  Int J Mol Sci       Date:  2020-09-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.